Protective role of melatonin in ochratoxin A toxicity in rat heart and lung

Journal of Applied Toxicology

Volumn 24, Issue 6, 2004, Pages 505-512

  Okutan, Huseyin ^a,b   Aydin, Gulsen ^a   Ozcelik, Nurten ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Department of Pathology ^*  (Turkey)

Author keywords

Heart; Histopathological changes; Lung; Melatonin; Ochratoxin A

Indexed keywords

MELATONIN; MYCOTOXIN; OCHRATOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM VESICLE; HEART; HEART MUSCLE NECROSIS; HEART PROTECTION; HISTOPATHOLOGY; LUNG; LUNG CONGESTION; LUNG TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; CARCINOGENS; HEART; INFLAMMATION; LUNG; MALE; MELATONIN; MYOCARDIUM; NECROSIS; OCHRATOXINS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

FUNGI;

EID: 9644254138     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.1010     Document Type: Article

References (47)

1. Abdel-Wahhab MA, Nada SA, Arbid, MS. 1999. Ochratoxicosis: prevention of developmental toxicity by L-methionine in rats. J. Appl. Toxicol. 19: 7-12.
2. Atroshi FB, Aizza A, Westermarck T, Ali-Vehmas T. 1998. Effects of tamoxifen, melatonin, coenzyme Q 10 and L-carnitine supplementation on bacterial growth in the presence of mycotoxins. Pharmacol. Res. 38: 289-295.
3. Atroshi F, Rizzo A, Sankari S, Biese I, Westermarck T, Veijainen P. 2000. Liver enzyme activities of rats exposed to ochratoxin A and T-2 toxin with antioxidant. Bull. Environ. Contam. Toxicol. 64: 586-592.
4. Aydin G, Özcelik N, Cicek E, Soyoz M. 2003. Histopathologic changes in liver and renal tissues induced by ochratoxin A and melatonin in rats. Hum. Exp. Toxicol. 22: 383-391.
5. Baudrimont I, Pfohl-Leszkowicz A, Betbeder AM, Gharbi A, Dirheimer G, Creppy EE. 1994. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology 89: 101-111.
6. Baudrimont I, Ahouandjivo R, Creppy EE. 1997. Prevention of the lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents. Chem. Biol. Interact. 104: 29-40.
7. Bauer J, Gareis M. 1987. Ochratoxin A in der Nahrungsmittelkette. Z. Vet. B34: 613-627.
8. Bendele AM, Carlton WW, Krogh P, Lillehoj EB. 1985. Ocratoxin A carcinogenesis in the (C 57BL/6JxC3H) F1 mause. J. Natl. Cancer Inst. 75: 733-742.
9. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuna-Castroviejo D, Guerrero J. 1996. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J. Pineal Res. 20: 205-210.
10. Breitholtz A, Olsen M, Dahlback A, Hult K. 1991. Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit. Contam. 8: 183-192.
11. Bunge I, Dirheimer G, Röschenthaler R. 1978. In vivo and in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem. Biophys. Res. Commun. 83: 398-405.
12. Castegnaro M, Chernozemshy I, Heitanen E, Bartsch H. 1990. Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers? Arch. Geschwulstforch. 60: 295-303.
13. Costa EJX, Lopes RH, Lamy-Freund MT. 1994. Permeability of pure lipid bilayers of melatonin. J. Pineal Res. 16: 123-124.
14. Creppy EE, Chakor K, Fisher MJ, Dirheimer G. 1990. The mycotoxin ochrotoxin A is a substrate for pheylalanine hydroxylase in isolated rat hepatocytes and in vivo. Arch. Toxicol. 64: 279-284.
15. Creppy EE, Baudrimont I, Betbeder AM. 1995. Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol. Lett. 82/83: 869-877.
16. Delibas N, Altuntas I, Yonden Z, Ozcelik N. 2003. Ochratoxin A reduces NMDA receptor subunits 2A and 2B concentration in rat hippocampus: partial protective effect of melatonin. Hum. Exp. Toxicol. 22: 335-339.
17. Gautier JC, Holzhaeuser D, Markovic J, Gremaud E, Schilter B, Turesky RJ. 2001. Oxidative damage and stress response from ochratoxin A exposure in rats. Free Rad. Biol. Med. 30: 1089-1098.
18. Grosse Y, Chekir-Ghedira L, Huc A, Obrecht-Pflumio S, Dirheimer G, Bacha H, Pfohl-Leszkowicz A. 1997. Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the rnycotoxins ochratoxin A and zearalenone. Cancer Lett. 114: 225-229.
19. Gupta M, Bandyopadhyay S, Paul B, Majumder S. 1979. Hematological changes produced in mice by ochratoxin A. Toxicology 14: 95-98.
20. Haubeck HD, Lorkowshi G, Kölsch E, Röschenthaler R. 1981. Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl. Environ. Microbiol. 41: 1040-1042.
21. Hohler D. 1999. Ochratoxin A in food and feed: occurrence, legislation and mode of action. Z Ernahrungswiss. 37: 2-12.
22. Hult K, Plestina R, Habazin-Novak V, Radic B, Ceovic S. 1982. Ochratoxin A in human blood and Balkan endemic nephropathy. Arch. Toxicol. 51: 313-321.
23. Kane A, Creppy EE, Röschenthaler R, Dirheimer G. 1986. Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 42: 233-243.
24. Khan S, Martin M, Bartsch H, Rahimtua AD. 1989. Perturbation of liver microsomal calcium homeostasis by ochratoxin A. Biochem. Pharmacol. 38: 67.
25. Krogh P, Nesheim S. 1982. Ochratoxin A. In Environmental Carcinogens, Stoloff L, Castegnaro M, Scott P, O'Neill IK. Bartsch II (eds), IARC Scientific Publications No. 44. IARC: Lyon, France; 247-259.
26. Li S, Marquardt R, Frohlich AA. 2000. Identification of ochratoxins and some of their metabolites in bile and urine of rats. Food Chem. Toxicol. 38: 141-152.
27. Marquardt R, Frohich AA. 1992. Review of recent advances in understanding ochratoxicosis. J. Anim. Sci. 70: 3968-3988.
28. Mayura K, Parker R, Brendt WO, Phillips TD. 1984. Ochratoxin A induced teratogenesis in rats; partial protection by phenylalanine. Appl. Environ. Microbiol. 48: 1186-1188.
29. Meki AR, Hussein AA. 2001. Melatonin reduces oxidative stress induced by ochratoxin A in rat live and kidney. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 130: 305-313.
30. More J, Camguilhem R. 1978. Effects of low doses of ochratoxin A after intratesticular injection in the rat. Experientia 35: 890-892.
31. Ohta Y, Kongo M, Sasaki E, Nishida K, Ishiguro I. 2000. Therapeutic effect of melatonin on carbon tetrachloride-induced acute liver injury in rats. J. Pineal Res. 28: 119-126.
32. Omar RF, Hasinoff BB, Mejilla F, Rahimtula AD. 1990. Mechanism of ochratoxin A stimulated lipid peroxidation. Biochem. Pharmacol. 40: 1183-1191.
33. Omar RF, Rahimtula AD, Bartsch H. 1991. Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. J. Biochem. Toxicol. 6: 203-209.
34. Ozcelik N, Kosar A, Soysal D. 2001. Ochratoxin A in human serum samples collected in Isparta, Turkey from healthy individuals suffering from different urinary disorders. Toxicol. Lett. 121: 9-13.
35. Packer JE. 1995. Oxidative stress, antioxidants, ageing and disease. In Oxidative Stress and Ageing, Gulter RG, Packer LB, Eratum J, Mori A (eds). Birkhauser Verlag: Basle; 152-163.
36. Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. 1988. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit. Contam. 5: 299-301.
37. Petzinger E, Ziegler K. 2000. Ochratoxin A from a toxicological perspective. J. Vet. Pharmacol. Ther. 23: 91-98.
38. Pitout MJ. 1968. The effect of ochrotoxin A on glycogen storage in rat liver. Toxicol. Appl. Pharmacol. 13: 299-306.
39. Rahimtula AD, Berziat JC, Bussacchini-Griot V, Bartsch H. 1988. Lipid peroxidation as possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 37: 4469-4477.
40. Reiter RJ. 1995. Oxidative processes and antioxidative defence mechanisms in the aging brain. FASEB J. 9: 526-533.
41. Reiter RJ. 1998. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56: 359-384.
42. Reiter RJ, Tan DX, Cabrera J. 1999. The oxidant/antioxidant network: role of melatonin. Biol. Signals Recept. 8: 56-63.
43. Shida CS, Castrucci AML, Lamy-Freund MTC. 1994. High melatonin solubility in aqueous medium. J. Pineal. Res. 16: 198-201.
44. Subramanian S, Kanthasamy A, Balasubramanian N, Sekar N, Govindasamy S. 1989. Ochratoxin A toxicity on carbonhydrate metabolism in rats. Bull. Environ. Contam. Toxicol. 43: 180-184.
45. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. 1993. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1: 57-60.
46. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkonson CW, Matsumoto AM, Rasmussen DD. 2000. Daily melatonin administration to middle-aged male rats supresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 141: 487-497.
47. Van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron JJ. 1965. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 13: 1112-1113.